VIP and VIP gene silencing modulation of differentiation marker N-cadherin and cell shape of corneal endothelium in human corneas ex vivo

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 8, 2008, Pages 3491-3498

  Koh, Shay Whey M ^a   Chandrasekara, Krish ^b   Abbondandolo, Cara J ^a   Coll, Timothy J ^a   Rutzen, Allan R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Transgenetech   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZARIN RED S; CONNEXIN 43; LENTIVIRUS VECTOR; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PROTEIN BCL 2; SHORT HAIRPIN RNA; VASOACTIVE INTESTINAL POLYPEPTIDE; BIOLOGICAL MARKER; CADHERIN;

AGED; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CADAVER; CASE REPORT; CELL DIFFERENTIATION; CELL SHAPE; CONTROL GROUP; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA LIMBUS; EX VIVO STUDY; EXPLANT; EYEBANK; FEMALE; GENE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; VASOACTIVE INTESTINAL PEPTIDE GENE; WESTERN BLOTTING; ANIMAL; CATTLE; CORNEA; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE VECTOR; GENETICS; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; RNA INTERFERENCE; SCLERA;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CADHERINS; CATTLE; CELL DIFFERENTIATION; CELL SHAPE; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, CORNEAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; GENE SILENCING; GENETIC VECTORS; HUMANS; ORGAN CULTURE TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; SCLERA; VASOACTIVE INTESTINAL PEPTIDE;

EID: 49049104616     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1543     Document Type: Article

References (52)

1. Waring GO, Bourne WM, Edelhauser HF, Kenyon KR. The corneal endothelium: normal and pathologic structure and function. Ophthalmology. 1982;89:531-590.
2. Johnston MC, Noden, DM, Hazelton RD, Coulombre JL, Coulombre AJ. Origins of avian ocular and periocular tissues. Exp Eye Res. 1979;29:27-43.
3. LeLievre CS, LeDouarin NM. Mesenchymal derivatives of the neural crest: analysis of chimaeric quail and chick embryos. J Embryo Exp Morphol. 1975;34:125-154.
4. Noden DM. The control of avian cephalic neural crest cytodifferentiation, I: skeletal and connective tissues. Dev Biol. 1978;67:296-312.
5. Hayashi K, Sueishi K, Tanaka K, et al. Immunohistochemical evidence of the origin of human corneal endothelial cells and keratocytes. Graefes Arch Clin Exp Ophthalmol. 1986;224:452-456.
6. Adamis AP, Molnar ML, Tripathi BJ, Emmerson MS, Stefansson K, Tripathi RC. Neuron-specific enolase in human corneal endothelial cells and posterior keratocytes. Exp Eye Res. 1985;41:665-668.
7. Joyce NC. Proliferative capacity of the corneal endothelium. Pro Retin Eye Res. 2003;22:359-389.
8. Beebe DC, Coats JM. The lens organizes the anterior segment: specification of neural crest cell differentiation in the avian eye. Dev Biol. 2000;220:424-431.
9. Reneker LW, Silversides DW, Xu L, Overbeek PA. Formation of corneal endothelium is essential for anterior segment development-a transgenic mouse model of anterior segment dysgenesis. Development. 2000;127:533-542.
10. Derycke LDM, Bracke, ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signaling. Int J Dev Biol. 2004;48:463-476.
11. Carthew RW. Adhesion proteins and the control of cell shape. Curr Opin Genet Dev. 2005;15:358-363.
12. Hayashi T, Carthew RW. Surface mechanics mediate pattern formation in the developing retina. Nature. 2004;431:647-652.
13. Togashi H, Abe K, Mizoguchi A, Takaoka K, Chisaka O, Takeichi M. Cadherin regulates dendritic spine morphogenesis. Neuron. 2002;35:77-89.
14. El Sayegh TY, Arora PD, Laschinger CA, et al. Cortactin associates with N-cadherin adhesions and mediates intercellular adhesion strengthening in fibroblasts. J Cell Sci. 2004;117:5117-5131.
15. Chan MWC, El Sayegh TY, Arora PD, et al. Regulation of intercellular adhesion strength in fibroblasts. J Biol Chem. 2004;279:41047-41057.
16. Gavard J, Marthiens V, Monnet C, Lambert M, Mege RM. N-cadherin activation substitutes for the cell contact control in cell cycle arrest and myogenic differentiation: involvement of p120 and β-catenin. J Cell Sci. 2004;117:257-270.
17. Gavard J, Lambert M, Grosheva I, et al. Lamellipodium extension and cadherin adhesion: two cell responses to cadherin activation relying on distinct signalling pathways. J Biol Chem. 2004;279:36795-36802.
18. Tran NL, Adams DG, Vaillancourt RR, Heimark RL. Signal transduction from N-cadherin increases Bcl-2: regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem. 2002;277:32905-32914.
19. Koutsouki E, Beeching CA, Slater SC, Blaschuk OW, Sala-Newby GB, George SJ. N-cadherin dependent cell-cell contacts promote human saphenous vein smooth muscle cell survival. Arterioscler Thromb Vasc Biol. 2005;25:982-988.
20. MacCalman CD, Getsios S, Farookhi R, Blaschuk OW. Estrogen potentiates the stimulatory effects of follicle-stimulating hormone on N-cadherin messenger ribonucleic acid levels in cultured mouse Sertoli cells. Endocrinology. 1997;138:41-48.
21. Bozdagi O, Shan W, Tanaka H, Benson DL, Huntley GW. Increasing numbers of synaptic puncta during late-phase LTP: N-cadherin is synthesized, recruited to synaptic sites, and required for potentiation. Neuron. 2000;1:245-259.
22. Koh S-WM, Yue BYJT. VIP stimulation of cAMP production in cultures of rabbit corneal endothelial cells. Cornea. 2002;21:270-274.
23. Ishihara TR, Shigemoto K, Mori K, Takahashi, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 1992;8:811-819.
24. Lutz, EM, Sheward WJ, West KM, Morrow JA, Frank G, Harmar AJ. The VIP2 receptors: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 1993;334:3-8.
25. Langer I, Robberecht P. Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation. Cell Signal. 2005;17:17-24.
26. Brecha NC, Eldred W, Kuljis RO, Karten HJ. Identification and localization of biologically active peptide in the vertebrate retina. In: Chader G, Osborne N, eds. Progress in Retinal Research. 1984;185-226.
27. Stone RA. Vasoactive intestinal polypeptide and ocular innervation. Invest Ophthalmol Vis Sci. 1984;27:951-957.
28. Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev. 2004;56:249-290.
29. Koh S-WM, Waschek JA. Corneal endothelial cell survival in organ cultures under acute oxidative stress: effect of VIP. Invest Ophthalmol Vis Sci. 2000;41:4085-4092.
30. Koh SW, Guo Y, Bernstein SL, Waschek JA, Liu X, Symes AJ. Vasoactive intestinal peptide induction by ciliary neurotrophic factor in donor human corneal endothelium in situ. Neurosci Lett. 2007;16:89-94.
31. Koh SW. Ciliary neurotrophic factor released by corneal endothelium surviving oxidative stress ex vivo. Invest Ophthalmol Vis Sci. 2002;43:2887-2896.
32. Taylor AW, Streilein JW, Cousins SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol. 1994;153:1080-1086.
33. Troger J, Kieselbach G, Gottinger W, Metzler R, Kahler C, Saria A. Different concentrations of vasoactive intestinal peptide in aqueous humor of patients with proliferative vitreoretinopathy and cataract patients. Ger J Ophthalmol. 1994;3:245-247.
34. Koh S-WM, Rutzen AR, Coll TJ, Hemady RK, Higginbotham EJ. VIP-immunoreactivity in human aqueous humor. Curr Eye Res. 2005;30:189-194.
35. Collado B, Gutierrez-Canas I, Rodriguez-Henche N, Prieto JC, Carmena MJ. Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells. Regul Pept. 2004;119:69-75.
36. Gutierrez-Canas I, Juarranz MG, Collado B, et al. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K. Prostate. 2005;63:44-55.
37. Heraud C, Hilairet S, Muller JM, Leterrier JF, Chadeneau C. Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5y cells is associated with regulated expression of cytoskeleton mRNAs and proteins. J Neurosci Res. 2004;75:320-329.
38. Alleaume C, Eychene A, Harnois T, et al. Vasoactive intestinal peptide-induced neurite remodeling in human neuroblastoma SHSY5Y cells implicates the Cdc42 GTPase and is independent of Ras-ERK pathway. Exp Cell Res. 2004;299:511-524.
39. Koh S-WM, Kane GJ. VIP stimulates proliferation and differentiation of the cultured retinal pigment epithelium with disparate potencies. Cell Biol Int Rep. 1992;16:175-183.
40. Koh S-WM, Yeh T-H, Morris SM, et al. Vasoactive intestinal peptide stimulation of human trabecular meshwork cell growth. Invest Ophthalmol Vis Sci. 1997;38:2781-2789.
41. Wang X, Appukuttan B, Ott S, et al. Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector. Gene Ther. 2000;7:196-200.
42. Bainbridge JW, Stephens C, Parsley K, et al. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector: efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther. 2001;8:1665-1668.
43. Beutelspacher SC, Ardjomand N, Tan PH, et al. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp Eye Res. 2005;80:787-794.
44. Parker DG, Kaufmann C, Brereton HM, et al. Lentivirus-mediated gene transfer to the rat, ovine and human cornea. Gene Ther. 2007;14:760-767.
45. Chen Q, Chen TJ, Letourneau PC, Costa Lda F, Schubert D. Modifier of cell adhesion regulates N-cadherin-mediated cell-cell adhesion and neurite outgrowth. J Neurosci. 2005;25:281-290.
46. Lee HS, Tomarev SI. Optimedin induces expression of N-cadherin and stimulates aggregation of NGF-stimulated PC12 cells. Exp Cell Res. 2007;313:98-108.
47. Chen Z, de Paiva CS, Luo L, Kretzer FL, Pflugfelder SC, Li DQ. Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells. 2004;22:355-366.
48. Le Mee S, Fromigue O, Marie PJ. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res. 2005;302:129-142.
49. Zhang J, Wang S, Wesley RA, Danner RL. Adjacent sequence controls the response polarity of nitric oxide-sensitive Sp factor binding sites. J Biol Chem. 278:29192-291200, 2003.
50. Zheng XL, Matsubara S, Diao C, Hollenberg MD, Wong NC. Activation of apolipoprotein AI gene expression by protein kinase A and kinase C through transcription factor, Sp1. J Biol Chem. 2000;275:31747-3154.
51. Ongeri EM, Verderame MF, Hammond JM. Follicle stimulating hormone induction of ovarian IGF binding protein-3 transcription requires a TATA-box binding protein, and the PKA and PI-3 kinase pathways. Mol Endocrinol. 2005;19:1837-1848.
52. An DS, Qin FX, Auyeung VC, et al. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol Ther. 2006;14:494-504.